RE:AGN now investigating CKD treatmentStawkHawk1, so how do you think these guys will pay for CKD trial? They can only raise $1.2M on rights offering, don't have the funds to complete current trials/ideas, they spin out stroke program as can't finance it. Why can't management pick an indication and do a trial right, not spend huge portion of investors money on stock promotion (they call it marketing, however need an actual product to do marketing)? So what do you think, or are you paid by company to put up theses distracting posts?